Contract facts
UnrestrictedNo full NAICS 621511 intel page yet. Browse NAICS intelligence
STATSTRIP GLUCOSE METER WITH 45 STATSTRIP GLUCOSE STRIPS DELIVERY. is a federal Unrestricted award for Defense Health Agency Hcd West held by Nova Biomedical Corp. Estimated value $219K ($155K obligated). Current period of performance ends Jan 17, 2026 (potential Jan 17, 2028). Last award drew 1 bidder. Place of performance: CAMP PENDLETON CA. Related solicitation HT941023N0003.
STATSTRIP GLUCOSE METER WITH 45 STATSTRIP GLUCOSE STRIPS DELIVERY.
Recompete timing
PublicCurrent PoP ended Jan 17, 2026 (253 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on HT941023P0014? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordNova Biomedical Corp — $2.5M obligated across 67 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT941023P0014?
HT941023P0014 (Statstrip glucose METER WITH 45 statstrip) is a Defense Health Agency Hcd West award with a potential value of $219K, currently held by Nova Biomedical Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT9410-23-P-0014?
HT9410-23-P-0014 is the dashed form of PIID HT941023P0014 (Statstrip glucose METER WITH 45 statstrip), held by Nova Biomedical Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT941023P0014?
Defense Health Agency Hcd West awarded HT941023P0014 to Nova Biomedical Corp (potential $219K).
Who is the incumbent on HT941023P0014?
Nova Biomedical Corp is the incumbent with $2.5M across 67 related awards in SCOUT’s public footprint. The current period of performance ends Jan 17, 2026.
When does Nova Biomedical Corp’s HT941023P0014 come up for recompete?
SCOUT tracks a period-of-performance end of Jan 17, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HT941023P0014? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.